Skip to main content
Erschienen in: Virchows Archiv 2/2020

Open Access 19.03.2020 | Original Article

Prominent entrapment of respiratory epithelium in primary and metastatic intrapulmonary non-epithelial neoplasms: a frequent morphological pattern closely mimicking adenofibroma and other biphasic pulmonary lesions

verfasst von: Ramona Erber, Florian Haller, Arndt Hartmann, Abbas Agaimy

Erschienen in: Virchows Archiv | Ausgabe 2/2020

Abstract

As one of the most common target organs for hematogenous spread from diverse cancers, biopsy interpretation of lung tumors is complicated by the challenging question of primary versus metastatic and by frequent entrapment of native respiratory glands. Nevertheless, the literature dealing with this issue is surprisingly sparse and no single study has been devoted to this topic. We reviewed 47 surgical lung specimens of non-epithelial neoplasms (38 metastases, mainly from sarcomas and 9 primary lesions) for frequency and pattern of intralesional epithelial entrapment. Respiratory epithelium entrapment was noted in 23/47 (49%) cases (diffuse in 15 and peripheral in 8). Entrapped glands frequently showed prominent regenerative and reactive changes mimicking neoplastic glands. Based on cellularity of the mesenchymal component and the extent, distribution and shape of entrapped respiratory glands, four morphological patterns were recognized: paucicellular sclerosing low-grade neoplasms containing leaflet-like glands indistinguishable from adenofibroma and fibroepithelial hamartomas (n = 11), and biphasic cellular lesions mimicking adenomyoepithelioma (n = 1), biphasic synovial sarcoma (n = 2), and pleuropulmonary blastoma (n = 1). Only a single genuine pulmonary adenofibroma was identified. This study highlights frequent respiratory epithelium entrapment in diverse non-epithelial lung tumors, both primary and metastatic. Recognition of this finding and use of adjunct IHC combined with clinical history should help to avoid misinterpretation as primary pulmonary biphasic neoplasm or as harmless adenofibroma. The vast majority of morphologically defined lung adenofibromas represent adenofibroma-like variants of histogenetically diverse entities so that a diagnosis of adenofibroma should be rendered only very restrictively and then as a diagnosis by exclusion.
Hinweise

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

The lungs represent major target organs for metastatic deposits from malignant neoplasms of diverse histogenetic origin from different anatomic sites. Sarcomas in particular are known to have significant predilection for hematogenous spread to the lungs. Accordingly, thoracic imaging represents an integral part of routine staging investigations for newly diagnosed malignant neoplasms and on follow-up for patients with a history of malignancy. As a consequence of increasing use of high-resolution imaging and increasing frequency of thoracoscopic surgery, incidental pulmonary nodules are being increasingly discovered and excised. Familiarity with the diverse patterns of primary and metastatic intrapulmonary non-epithelial neoplasms is mandatory for distinguishing benign from malignant and primary from metastatic diseases.
A subset of incidentally discovered pulmonary nodules, whether solitary or multiple, represent hamartomatous lesions or benign mesenchymal neoplasms, chondroid hamartomas being the most frequent. Pulmonary adenofibroma (PAF) is an exceptionally rare benign fibroepithelial lesion that closely recapitulates Müllerian adenofibroma of the genital tract [1] or fibroadenoma of the breast [2]. Since its first description by Scarff and Gowar in 1944 [3] and delineation as distinctive entity by Suster and Moran in 1993 [1], only a few cases of genuine PAFs have been described [4, 5].
Although entrapment of native pulmonary epithelium by metastatic neoplasms in the lung is well known, in our experience this phenomenon and the pitfalls related to it have not received sufficient attention in the surgical pathology literature, possibly explaining its under-recognition among general surgical pathologists in routine practice. Encountering several cases that have illustrated the difficulty and confusion related to this finding, we decided to review our files for non-epithelial pulmonary lesions, both primary and metastatic, to critically address and illustrate this histological finding and discuss the sources of pitfall in the context of the differential diagnoses of biphasic pulmonary lesions.

Material and methods

We searched our routine and consultation files for surgically excised lung metastases from malignant neoplasms other than carcinomas (including sarcoma of different types, embryonal tumors, and germ cell tumors) diagnosed in our institution between 2012 and 2018. Furthermore, our archive was searched for lung lesions diagnosed as adenofibroma, perivascular epithelioid cell tumor (PEComa), and solitary fibrous tumors (SFT). Diagnosis, site of origin, patient’s age, gender, and history of malignancy were drawn from the original pathology records. To have a representative overview of this morphological phenomenon, only surgical specimens were analyzed. In each case, all resected lung metastases have been reviewed and the presence, pattern, and extent of entrapped lung epithelium have been recorded (described as diffuse resulting in a biphasic pattern throughout versus focal and peripheral). Those cases with diffuse entrapment of respiratory epithelium were then used for further analysis. In most cases, immunohistochemical staining (CK7, TTF1, and NapsinA, in addition to other markers based on the exact diagnosis in a given case) was available. The overall histological appearance of the lesion was then described as adenofibroma-like, adenomyoepithelioma-like, biphasic synovial sarcoma–like, and other non-descript biphasic patterns.

Results

General clinical and demographic features

Forty-seven patients were retrieved for histological analysis. These comprised 38 patients with pulmonary metastases (81%) and 8 cases of primary pulmonary non-epithelial lesions (6 primary intrapulmonary SFTs, one SMARCB1-deficient fibromyxoid lung neoplasm of uncertain histogenesis, and one pulmonary adenofibroma). One PEComa could not be determined whether it is primary or metastatic due to lack of detailed clinical information. The 38 cases of lung metastases were from different sarcoma types (n = 35), germ cell tumors (n = 2), and Wilms tumor (n = 1). Age of the patients ranged between 2 and 84 years (median 52 years, mean 47 years). Twenty-one patients were females (44.7%). Eighteen patients suffered from ≥ 2 lung metastases; one patient had > 30 small lung metastases that were resected. Patient characteristics are shown in Table 1.
Table 1
Patient characteristics of the study cohort (47 patients)
No
Age years
Entrapment of alveolar respiratory epithelium
Histological pattern
Metastasis (number) vs primary
Site within the lung
Histological diagnosis
History of malignancy
1
33
No
No
MTS
Both sites
High-grade sarcoma NOS
High malignant epithelioid sarcoma NOS DDx Ewing sarcoma
2
17
No
No
MTS
Left superior lobe
Angiectatic osteosarcoma
Osteosarcoma right distal femur2014
3
66
No
No
MTS (M)
Right lobes, left inferior lobe
Leiomyosarcoma
Leiomyosarcoma
4
18
No
No
MTS (M)
Both sites
Osteosarcoma
Osteosarcoma 03/2016, resection of lung metastases 03/2017 and 10/2017
5
51
Diffuse
Fibroadenoma-like
MTS
Right and left inferior lobe
Leiomyosarcoma
Leiomyosarcoma of the uterus, bone metastasis 01/2017
6
63
No
No
MTS (2)
Left superior and inferior lobe
Synovial sarcoma
Synovial sarcoma left popliteal cavity 09/2015
7
72
Diffuse
Fibroadenoma-like
MTS (M)
Left superior and inferior lobe
Myxofibrosarcoma
Myxofibrosarcoma with lung metastases 10/2016, resection after radiochemotherapy
8
15
No
No
MTS
NOS
Osteosarcoma
Osteosarcoma distal tibia 11/2016
9
75
No
No
MTS
Right inferior lobe
Pleomorphic sarcoma
Recurrent UPS right shoulder 11/2015, synchronous carcinoid of the right lung, pericardial metastasis of the sarcoma
10
11
No
No
MTS
NOS
Ewing sarcoma/PNET family
Malignancy of Ewing sarcoma/PNET family 06/2015
11
72
No
No
MTS
Left inferior lobe
Synovial sarcoma
Synovial sarcoma right lower leg 2014
12
84
Peripheral
No
MTS
Right superior lobe
Leiomyosarcoma
Leiomyosarcoma of the mandible (lung metastases 2014 and 2016 resected), lung metastasized colorectal carcinoma 2014 (status post radiochemotherapy), prostate cancer
13
57
Peripheral
No
MTS (M)
NOS
Sarcoma NOS
Breast cancer 2015
14
11
No
No
MTS (M)
Both sites
Synovial sarcoma
Synovial sarcoma with multiple lung metastases (resected 2014, 2016 and 2017)
15
42
Diffuse
Adenomyoepithelioma-like
MTS (M, >30)
Right
Sarcomatous transformed atypical fibrous histiocytoma
Sarcomatous transformed atypical fibrous histiocytoma
16
43
No
No
MTS (M)
Right
Leiomyosarcoma
Leiomyosarcoma of the right parotid
17
50
No
No
MTS
Left superior lobe
High-grade sarcoma NOS
1999 leiomyosarcoma of the vagina
18
64
Peripheral
No
MTS
NOS
High-grade leiomyosarcoma
Status post tumor of the testis
19
58
No
No
MTS (M)
Right
Osteosarcoma
Undifferentiated pleomorphic sarcoma of left thigh 2013
20
66
No
No
MTS
NOS
UPS/myxoid fibrosarcoma grade 3
Myxoid fibrosarcoma grade 3 of the thigh 2009
21
14
Peripheral
No
MTS
Both sites
Low-grade fibromyxoid sarcoma
Low grade fibromyxoid sarcoma 2008, lung metastases resected 2014
22
35
Diffuse
Biphasic synovial sarcoma–like
MTS (M)
Both sites
Synovial sarcoma
Initial diagnosis of malignant peripheral nerve sheath tumor right foot (retrospectively monophasic synovial sarcoma), status post radiochemotherapy and amputation of the lower leg
23
52
No
No
MTS
Left superior lobe
Low-grade fibromyxoid sarcoma/ epithelioid fibrosarcoma
Low-grade fibromyxoid sarcoma/ epithelioid fibrosarcoma of the thigh
24
56
No
No
MTS (2)
Right superior and inferior lobe
Osteosarcoma
Osteosarcoma
25
60
No
No
MTS (M)
Left superior and inferior lobe
Leiomyosarcoma
High grade pleomorphic leiomyosarcoma (non-genital type) pelvic/retroperitoneal 2013, status post radiochemotherapy, resection of primary and of liver metastasis 2014
26
20
No
No
MTS
Right inferior lobe
Ewing sarcoma
Ewing sarcoma of the left thoracic wall
27
56
Diffuse
Fibroadenoma-like
MTS (M)
Right middle and inferior lobe
Sclerosing fibroblastic sarcoma
Sclerosing fibroblastic sarcoma retroperitoneal/pelvic wall, resection of lung metastases 2012 and 2013
28
70
Peripheral
No
MTS
Right inferior lobe
High-grade leiomyosarcoma
Leiomyosarcoma of the uterus 1991
29
48
No
No
MTS
Right superior lobe
Sarcoma NOS
Retroperitoneal SFT 2006
30
62
Diffuse
Fibroadenoma-like
Primary
NOS
Primary myxoid (myoepithelial!) neoplasm NOS (SMARCB1 deficiency)
Unknown
31
57
Peripheral
No
primary
Left inferior lobe
SFT
Unknown
32
66
Diffuse
Fibroadenoma-like
Primary
Pleura/lung
Intrapulmonary SFT (fibroadenoma-like variant)
Unknown
33
65
Peripheral
No
Primary
Pleura/lung
SFT
Malignant melanoma 2014, malignant biphasic mesothelioma (high grade)
34
20
Diffuse
Pulmonary blastoma–like
MTS
NOS
Embryonal rhabdomyosarcoma
Primary diagnosed in 2015, metastasis in 2017
35
64
Diffuse
Fibroadenoma-like
Primary
Right inferior lobe
Pulmonary adenofibroma
Unknown
36
2
Diffuse
Fibroadenoma-like
MTS (M)
Right superior lobe, right inferior lobe, left superior lobe
Wilms tumor
Wilms tumor at age of 2 years (10/2017), stage IV (lung metastases), status post neoadjuvant chemotherapy
37
54
No
No
MTS
Right middle lobe
Malignant bone tumor DDx osteosarcoma
1985 diagnosis of malignant “osteoblastoma” (radius), status post extirpation, re-extirpation due to recurrence, radiochemotherapy
38
66
Diffuse
Fibroadenoma-like
Uncertain
Left inferior lobe
Sclerosing cystic PEComa DD lung clear cell “sugar” tumor DDx metastasis of genital PEComa
Unknown
39
26
Diffuse
Fibroadenoma-like
MTS (2)
Right and left lung
Testicular teratoma
Concurrent testicular teratoma
40
31
No
No
MTS
Left inferior lobe
Germ cell tumor (embryonal carcinoma component)
Mixed germ cell tumor of the testis (embryonal carcinoma and seminoma and mature teratoma) with lung metastasis 2018
41
38
No
No
MTS
NOS
Atypical fibrous histiocytoma
2010 histiocytoma, 2014 recurrence, 2016 lung metastases
42
28
Diffuse
Fibroadenoma-like
MTS (M)
NOS
Sclerosing epithelioid fibrosarcoma of kidney
Unclassified tumor kidney region, treated as Wilms tumor
43
68
Diffuse
Fibroadenoma-like
Primary
Intrathorakal/lung
Partly intrapulmonary SFT (fibroadenoma like variant)
Unknown
44
48
Diffuse
Biphasic synovial sarcoma–like
MTS
NOS
Spindle cell sarcoma unclassified (adult fibrosarcoma)
Tumor of the lower extremity
45
41
No
No
MTS
NOS
MPNST
Recurrent MPNST peroneal nerve
46
62
No
No
Pleuropulmonary SFT
Lung/pleura (right lower lobe)
Recurrence of SFT with malignant (fibrosarcoma like) features
SFT (2012)
47
48
Peripheral
No
Primary
Right lower lobe
Intrapulmonary SFT, marked adenofibroma like features
Unknown
DDx, differential diagnosis; MPNST, malignant peripheral nerve sheath tumor; MTS, metastasis; (M), multiple; NA, not assessable; NOS, not otherwise specified; PEComa, perivascular epithelioid cell tumor; PNET, primitive neuroectodermal tumor; SFT, solitary fibrous tumor; UPS, undifferentiated pleomorphic sarcoma

Frequency of respiratory/alveolar epithelium entrapment

In total, 23 out of 47 cases (49%) showed entrapment of respiratory/alveolar epithelium with variable extent. In eight of these cases, entrapped pulmonary epithelium was seen mainly in the peripheral portion of the tumor and was clearly evident as secondary entrapment of lung tissue as the tumor grows peripherally. The remainder (n = 15), which represent the basis of the subsequent morphological analysis, showed prominent entrapped alveolar and respiratory epithelium that was seen throughout the lesion albeit to varying extent. These entrapped glands frequently showed reactive/regenerative appearance with occasional hobnail-like nuclear prominence, vesicular chromatin, and irregular configuration mimicking neoplastic glands, but lacked significant cytological atypia. The gland size varied greatly from small acinar-type glands or microcystic spaces lined by flattened epithelial cells and containing mucoid secretion to branching leaflet-like papillary spaces. The overall appearance of these glands was different from normal alveoli, thus enhancing their confusion with true neoplastic glands. Based on the cellularity of the background neoplasm, four different histological patterns were recognized: (1) lesions closely mimicking PAF (11/15); (2) those closely mimicking adenomyoepithelioma/epithelial-myoepithelial carcinoma (1/15); (3) biphasic synovial sarcoma–like (2/15); and (4) pulmonary blastoma–like (1/15) patterns (Figs. 1, 2, and 3, Table 2).
Table 2
Entrapment of alveolar/respiratory epithelium in different primary and metastatic pulmonary lesions
Category
Subcategory
No of cases
Entrapment of lung epithelium
No of cases
Number of adenofibroma-like cases
Number of adenomyoepithelial-like cases
Number of biphasic synovial sarcoma–like cases
Number of pulmonary blastoma–like cases
Lung primary
 
8
Peripheral
3
0
0
0
0
   
Diffuse
4
4
0
0
0
 
SFT
6
Peripheral
3
0
0
0
0
   
Diffuse
2
2
0
0
0
 
Pulmonary adenofibroma
1
Diffuse
1
1
0
0
0
 
Myxoid sarcomatoid neoplasm NOS of the lung (SMARCB1 deficient)
1
Diffuse
1
1
0
0
0
Primary or metastasis
Sclerosing cystic PEComa
1
Diffuse
1
1
0
0
0
Lung metastasis
 
38
Peripheral
5
0
0
0
0
   
Diffuse
10
6
1
2
1
 
Leiomyosarcoma
7
Peripheral
3
0
0
0
0
   
Diffuse
1
1
0
0
0
 
Ewing sarcoma/PNET family
2
Peripheral
0
0
0
0
0
   
Diffuse
0
0
0
0
0
 
Osteosarcoma/malignant bone tumor
6
Peripheral
0
0
0
0
0
   
Diffuse
0
0
0
0
0
 
Synovial sarcoma
4
Peripheral
0
0
0
0
0
   
Diffuse
1
0
0
1
0
 
Myxofibrosarcoma
1
Diffuse
1
1
0
0
0
 
Pleomorphic sarcoma/myxoid fibrosarcoma grade 3
2
Peripheral
0
0
0
0
0
   
Diffuse
0
0
0
0
0
 
Embryonal rhabdomyosarcoma
1
Diffuse
1
0
0
0
1
 
Low-grade fibromyxoid sarcoma
2
Peripheral
1
0
0
0
0
   
Diffuse
0
0
0
0
0
 
Sarcoma NOS
5
Peripheral
1
0
0
0
0
   
Diffuse
1
1
0
0
0
 
Atypical fibrous histiocytoma
2
Peripheral
0
0
0
0
0
   
Diffuse
1
0
1
0
0
 
Sclerosing epithelioid fibrosarcoma
1
Diffuse
1
1
0
0
0
 
Wilms tumor
1
Diffuse
1
1
0
0
0
 
Germ cell tumor
2
Peripheral
0
0
0
0
0
   
Diffuse
1
1
0
0
0
 
Spindle cell sarcoma unclassified (adult fibrosarcoma)
1
Diffuse
1
0
0
1
0
 
MPNST
1
Peripheral
0
0
0
0
0
   
Diffuse
0
0
0
0
0
MPNST, malignant peripheral nerve sheath tumor; NOS, not otherwise specified; PEComa, perivascular epithelioid cell tumor; PNET, primitive neuroectodermal tumor; SFT, solitary fibrous tumor

Adenofibroma-like pattern

This pattern (seen in 11/15 cases; 73%) was characterized by the presence of a diffuse component of branching leaflet-like variably dilated glands throughout the lesion imparting a characteristic adenofibroma-like, phylloides-like or fibroepithelial hamartoma–like pattern. This feature (which is restricted to spindle cell neoplasms with low-grade histological features and paucicellular sclerosing stroma) was seen in 4 primary intrapulmonary lesions (2 SFTs, 1 unclassified myxoid lesion, and 1 pulmonary adenofibroma), 1 PEComa (not clear if primary or metastatic), 4 metastases from different sarcoma types including multiple metastases from sclerosing epithelioid fibrosarcoma, 1 metastatic Wilms tumor, and 1 patient with two PAF-like lung nodules concurrent to a histologically identical mature testicular teratoma (Table 2). Notably, the Wilms tumor metastasis (post-treatment) contained prominent fibrous stroma entrapping an admixture of native respiratory epithelium as well as minute glands, positive for PAX8, negative with TTF1, indicating neoplastic epithelial origin. The metastatic sarcoma category contained different entities, but (except 1 leiomyosarcoma) all were of presumable fibroblastic histogenesis. Representative examples of these entities are illustrated in Fig. 2.
The two lung nodules from the patient with concurrent mature testicular teratoma showed concordant histology between the mesenchymal stromal component of both the testicular lesion and the lung nodules; both expressed desmin, smooth muscle actin (SMA), and pancytokeratin, but the epithelial components were discordant (Fig. 2j–l). Although it is impossible to definitely classify the lung lesions of this patient without molecular testing for chromosome 12p amplification, the concordant phenotypes and the clinical presentation are more consistent with metastatic disease but this remains unsolved.
Among the PAF-like lesions, only a single case in this group qualified as genuine PAF (1/11; 9%). The spindled stroma of this case expressed SMA while the entrapped epithelium was positive for NapsinA and TTF1 (Fig. 1). Both of epithelial and stromal components were negative with estrogen and progesterone receptors, STAT6, and marker for adenocarcinoma of the lung (MAdL).

Adenomyoepithelial-like pattern

One case of metastatic atypical fibrous histiocytoma presented as a moderately cellular spindle cell lesion entrapping numerous small acinar respiratory glands mimicking adenomyoepithelioma (Fig. 3a). Diagnosis of metastatic atypical fibrous histiocytoma would have been impossible without knowing the clinical history.

Biphasic synovial sarcoma–like pattern

A highly cellular spindle cell sarcoma with prominent evenly distributed small glands mimicking biphasic synovial sarcoma was seen in two examples: one patient with multiple lung metastases of monophasic spindle cell synovial sarcoma (Fig. 3c) and another with lung metastasis from unclassified fibrosarcoma-like spindle cell sarcoma (Fig. 3b). Positive CK7 and TTF1 stains ruled out neoplastic epithelial elements in both cases (Fig. 3d).

Pulmonary blastoma–like pattern

This least common pattern was seen in a case of lung metastasis from embryonal rhabdomyosarcoma that contained prominent entrapped cystic spaces lined by respiratory epithelium closely mimicking type II pleuropulmonary blastoma (Fig. 3e, f). Notably, this case was subjected to NGS testing and lacked DICER1 mutations, thus arguing against the possibility of primary metachronous pleuropulmonary blastoma in the setting of DICER1 syndrome.

Discussion

It is well known that cancer metastasis may reveal diverse secondary morphological patterns that contribute to the differential diagnostic confusion in a given case. This is particularly true for lung metastasis where metastatic deposits may entrap native respiratory epithelium closely mimicking a biphasic neoplasm. The confusion is further enhanced by the frequent observation of prominent reactive and/ or regenerative changes of entrapped native epithelial glands closely mimicking neoplastic elements. Over the years, we have encountered several metastatic lung lesions that have been mistaken for primary pulmonary malignancies (carcinosarcoma, adenomyoepithelial carcinoma, etc.) based on prominent entrapped native glandular component where the alveolar epithelial immunophenotype was misinterpreted as evidence of pulmonary origin. This prompted us to perform the current study.
In the present study, we identified and illustrated different morphological patterns adopted by primary or metastatic non-epithelial neoplasms in the lung. Based on the degree of cellularity and other characteristics of the neoplastic mesenchymal component and the pattern of entrapped native respiratory epithelium, the tumors we have analyzed closely mimicked a variety of benign or malignant, primary or metastatic pulmonary neoplasms. Exploration of the previous clinical history/imaging combined with careful assessment of the stromal characteristics for phenotypic hints was the key to correct diagnosis.
The biphasic pattern in lung metastasis, particularly from low-grade non-epithelial neoplasms/sarcomas, frequently obscures the original morphological pattern seen in the primary tumor and, instead, closely mimics benign or harmless hamartomatous lesions. Pulmonary adenofibroma (PAF) is the most frequent and the most striking and misleading pattern encountered in this study. Paucicellular intrapulmonary SFT is the main representative in this category. While some SFTs contain only focal PAF-like areas and are thus easily recognizable as adenofibromatous SFT variants, others were uniformly PAF-like. Their immunoprofile is otherwise indistinguishable from conventional SFTs. PAF-like SFTs represented up to 24% of intrapulmonary SFTs in a previous series [6]. Following discovery of STAT6-NAB2 gene fusions as driver events in most of SFTs, STAT6 IHC has emerged as highly sensitive and specific marker for SFT [79]. In the pre-STAT6 era however, many PAF-like SFTs were misclassified as PAF. This is because PAFs and SFTs otherwise share expression of CD99, CD34, bcl-2, and vimentin in their mesenchymal component [5, 10, 11]. Notably, 71% of PAFs were STAT6-positive and showed NAB2-STAT6 rearrangement, confirming PAF-like SFT [5]. In a previous study, 71% of PAFs expressed hormone receptors in the stroma but all SFTs were negative for estrogen receptor-α by IHC [5]. Based on these recent observations and our current study, the concept of PAF as a specific entity is questionable as most of putative PAFs seem to be classifiable as other distinctive entities. The molecular pathogenesis and histogenesis of the vanishingly rare genuine “PAF lesions” remains to be further studied.
Other entities that closely mimicked PAF in this study include metastatic Wilms tumor, mature teratoma, and sclerosing epithelioid fibrosarcoma. Admittedly, many of these entities would have been impossible to diagnose by morphology alone if the clinical history was not available and/or STAT6 (in cases of intrapulmonary SFT) IHC was not applied.
In this context, it is worth mentioning that lung metastasis from biphasic neoplasms (Müllerian adenosarcomas and malignant fibroepithelial tumors of breast, prostate, etc.) usually contains only the mesenchymal stromal component. Biphasic synovial sarcoma may be the main exception to this. Accordingly, any glandular component in a biphasic lung lesion should be considered to represent entrapped native epithelium until proven otherwise. Immunophenotyping of the epithelial glandular component and careful assessment of atypia within the glands should allow distinguishing reactive entrapped glands from genuine neoplastic epithelial component.
On the other hand, SFTs with high cellularity and spindle cell sarcomas metastatic to the lung might be mistaken for biphasic synovial sarcoma. In contrast to biphasic synovial sarcoma, the entrapped alveolar glands show consistent pneumocytic phenotype, which is not the case in synovial sarcoma glands (the latter are CK7+, TLE1+, TTF1-, NapsinA-). Furthermore, the presence of alveolar-type glands with prominent regenerative atypia can closely mimic primary biphasic lung malignancies, in particular carcinosarcoma, primary and metastatic sarcomatoid (dedifferentiated) adenocarcinoma, and adenomyoepithelioma (epithelial-myoepithelial carcinoma). Carcinosarcoma (sarcomatoid carcinoma) typically features frankly malignant glands and high-grade cytology in both components, and the stromal component is usually highly pleomorphic. Pulmonary adenomyoepithelioma may represent primary lung neoplasm or metastasis from a salivary gland primary (epithelial-myoepithelial carcinoma) [12]. Recognition of the myoepithelial phenotype in the stromal component is helpful in diagnosis as well as the clinical history. In addition, the spatial arrangements of the epithelium surrounded by clear cell myoepithelial component are typical. In doubtful cases, it seems that HRAS mutation testing is context-specific for epithelial-myoepithelial carcinoma [12]. The rare pneumocytic adenomyoepithelioma, which contains similar alveolar-type neoplastic glands associated with myoepithelial stromal component, might be challenging. However, the neoplastic nature of the epithelial component in pneumocytic adenomyoepithelioma has been recently questioned [13].
In summary, we herein illustrated pitfalls related to frequent florid entrapment of native pulmonary epithelium within primary and metastatic non-epithelial neoplasms closely mimicking a biphasic lesion and occasionally leading to erroneous diagnosis of a primary pulmonary neoplasm based on the pneumocytic immunophenotype of the glandular component. As genuine PAF is exceptionally rare and a PAF-like pattern can be frequently seen in a variety of primary (benign or malignant) and metastatic lung tumors, any PAF-like lung lesion should be approached very critically and the recent and remote clinical history evaluated for any extrapulmonary neoplasm. Accordingly, PAF should be considered a diagnosis by exclusion. Misdiagnosis of metastatic malignancies as a “harmless PAF” would have significant prognostic and therapeutic implications.

Acknowledgments

Special thanks to Gertrud Zimmermann and Natascha Leicht for technical support. Furthermore, we want to thank Dr. Denis Trufa for providing medical history of one case.

Compliance with ethical standards

Ethical responsibilities of authors section and compliance with ethical rules

Samples were used in accordance with ethical guidelines for the use of retrospective tissue samples provided by the local ethics committee of the Friedrich-Alexander University Erlangen-Nuremberg (ethics committee statements 24.01.2005 and 18.01.2012).

Conflict of interest

The authors declare that they have no conflicts of interest.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
1.
Zurück zum Zitat Suster S, Moran CA (1993) Pulmonary adenofibroma: report of two cases of an unusual type of hamartomatous lesion of the lung. Histopathology 23(6):547–551CrossRef Suster S, Moran CA (1993) Pulmonary adenofibroma: report of two cases of an unusual type of hamartomatous lesion of the lung. Histopathology 23(6):547–551CrossRef
2.
Zurück zum Zitat Tan BY, Tan PH (2018) A diagnostic approach to fibroepithelial breast lesions. Surg Pathol Clin 11(1):17–42 Tan BY, Tan PH (2018) A diagnostic approach to fibroepithelial breast lesions. Surg Pathol Clin 11(1):17–42
3.
Zurück zum Zitat Scarff RW, Gowar FJS (1944) Fibroadenoma of the lung. J Pathol Bacteriol 56:257–259 Scarff RW, Gowar FJS (1944) Fibroadenoma of the lung. J Pathol Bacteriol 56:257–259
4.
Zurück zum Zitat Kumar R, Desai S, Pai T, Pramesh CS, Jambhekar NA (2014) Pulmonary adenofibroma: clinicopathological study of 3 cases of a rare benign lung lesion and review of the literature. Ann Diagn Pathol 18(4):238–243 Kumar R, Desai S, Pai T, Pramesh CS, Jambhekar NA (2014) Pulmonary adenofibroma: clinicopathological study of 3 cases of a rare benign lung lesion and review of the literature. Ann Diagn Pathol 18(4):238–243
5.
Zurück zum Zitat Fusco N, Guerini-Rocco E, Augello C, Terrasi A, Ercoli G, Fumagalli C, Vacirca D, Braidotti P, Parafioriti A, Jaconi M, Runza L, Ananthanarayanan V, Pagni F, Bosari S, Barberis M, Ferrero S (2017) Recurrent NAB2-STAT6 gene fusions and oestrogen receptor-alpha expression in pulmonary adenofibromas. Histopathology 70(6):906–917 Fusco N, Guerini-Rocco E, Augello C, Terrasi A, Ercoli G, Fumagalli C, Vacirca D, Braidotti P, Parafioriti A, Jaconi M, Runza L, Ananthanarayanan V, Pagni F, Bosari S, Barberis M, Ferrero S (2017) Recurrent NAB2-STAT6 gene fusions and oestrogen receptor-alpha expression in pulmonary adenofibromas. Histopathology 70(6):906–917
6.
Zurück zum Zitat Rao N, Colby TV, Falconieri G, Cohen H, Moran CA, Suster S (2013) Intrapulmonary solitary fibrous tumors: clinicopathologic and immunohistochemical study of 24 cases. Am J Surg Pathol 37(2):155–166 Rao N, Colby TV, Falconieri G, Cohen H, Moran CA, Suster S (2013) Intrapulmonary solitary fibrous tumors: clinicopathologic and immunohistochemical study of 24 cases. Am J Surg Pathol 37(2):155–166
7.
Zurück zum Zitat Doyle LA, Vivero M, Fletcher CD, Mertens F, Hornick JL (2014) Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol 27(3):390–395 Doyle LA, Vivero M, Fletcher CD, Mertens F, Hornick JL (2014) Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol 27(3):390–395
8.
Zurück zum Zitat Tan SY et al (2017) Solitary fibrous tumors in pediatric patients: a rare and potentially overdiagnosed neoplasm, confirmed by STAT6 immunohistochemistry. Pediatr Dev Pathol 21:1093526617745431 Tan SY et al (2017) Solitary fibrous tumors in pediatric patients: a rare and potentially overdiagnosed neoplasm, confirmed by STAT6 immunohistochemistry. Pediatr Dev Pathol 21:1093526617745431
9.
Zurück zum Zitat Barthelmess S et al (2014) Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features. Am J Pathol 184(4):1209–1218 Barthelmess S et al (2014) Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features. Am J Pathol 184(4):1209–1218
10.
Zurück zum Zitat Sironi M, Rho B, Spinelli M (2005) Adenofibromatous pattern in a solitary fibrous tumor of the lung. Int J Surg Pathol 13(1):79 Sironi M, Rho B, Spinelli M (2005) Adenofibromatous pattern in a solitary fibrous tumor of the lung. Int J Surg Pathol 13(1):79
11.
Zurück zum Zitat Cavazza A, Rossi G, de Marco L, Putrino I, Pellegrino S, Piana S (2003) Pseudopapillary solitary fibrous tumor of the lung: pulmonary fibroadenoma and adenofibroma revisited. Pathologica 95(3):162–166 Cavazza A, Rossi G, de Marco L, Putrino I, Pellegrino S, Piana S (2003) Pseudopapillary solitary fibrous tumor of the lung: pulmonary fibroadenoma and adenofibroma revisited. Pathologica 95(3):162–166
12.
Zurück zum Zitat Hsieh MS, Chen JS, Lee YH, Chou YH (2016) Epithelial-myoepithelial carcinoma of the salivary gland harboring HRAS codon 61 mutations with lung metastasis. Int J Surg Pathol 24(3):227–231 Hsieh MS, Chen JS, Lee YH, Chou YH (2016) Epithelial-myoepithelial carcinoma of the salivary gland harboring HRAS codon 61 mutations with lung metastasis. Int J Surg Pathol 24(3):227–231
13.
Zurück zum Zitat Yuan L, Katabi N, Antonescu CR, Golden A, Travis WD, Rekhtman N (2020) Pulmonary myoepithelial tumors with exuberant reactive pneumocytes: proposed reclassification of so-called pneumocytic adenomyoepithelioma. Am J Surg Pathol 44(1):140–147 Yuan L, Katabi N, Antonescu CR, Golden A, Travis WD, Rekhtman N (2020) Pulmonary myoepithelial tumors with exuberant reactive pneumocytes: proposed reclassification of so-called pneumocytic adenomyoepithelioma. Am J Surg Pathol 44(1):140–147
Metadaten
Titel
Prominent entrapment of respiratory epithelium in primary and metastatic intrapulmonary non-epithelial neoplasms: a frequent morphological pattern closely mimicking adenofibroma and other biphasic pulmonary lesions
verfasst von
Ramona Erber
Florian Haller
Arndt Hartmann
Abbas Agaimy
Publikationsdatum
19.03.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 2/2020
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-020-02796-7

Weitere Artikel der Ausgabe 2/2020

Virchows Archiv 2/2020 Zur Ausgabe

Neu im Fachgebiet Pathologie